Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01876251
Title A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | ESP | BEL


No variant requirements are available.